Inventor · disambiguated record
Philippe Pouletty
Also filed as: POULETTY PHILIPPE · POULETTY PHILIPPE J · POULETTY PHILIPPE JACQUES
37 granted patents·33 pending applications·2,291 citations·filing 1989–2025
98Inventor score
Top patents by PatentIndex Score
70 records- 0196US5437990ASelective amplification of target polynucleotide sequencesUNIV LELAND STANFORD JUNIOR·Filed 1993·Granted Aug 1, 1995·501 cites·10 claims
- 0293US6410276B1Selective amplification of target polynucleotide sequencesUNIV LELAND STANFORD JUNIOR·Filed 1995·Granted Jun 25, 2002·242 cites·56 claims
- 0393US5612034ASuper-globuling for in vivo extended lifetimesREDCELL INC·Filed 1994·Granted Mar 18, 1997·110 cites·15 claims
- 0493US5135872AMatrix controlled method of delayed fluid delivery for assaysSANGSTAT MEDICAL CORP·Filed 1989·Granted Aug 4, 1992·154 cites·5 claims
- 0592US5766629AOral cyclosporin formulationsSANGSTAT MEDICAL CORP·Filed 1996·Granted Jun 16, 1998·116 cites·19 claims
- 0690US5843440ACellular and serum protein anchors for modulating pharmacokineticsREDCELL CANADA INC·Filed 1996·Granted Dec 1, 1998·135 cites·8 claims
- 0789US6249717B1Liquid medication dispenser apparatusSANGSTAT MEDICAL CORP·Filed 1997·Granted Jun 19, 2001·201 cites·20 claims
- 0887US6103233ACellular and serum protein anchors and conjugatesCONJUCHEM INC·Filed 1995·Granted Aug 15, 2000·55 cites·6 claims
- 0987US6090591ASelective amplification of target polynucleotide sequencesUNIV LELAND STANFORD JUNIOR·Filed 1995·Granted Jul 18, 2000·146 cites·22 claims
- 1082US9181564B2Use of bacteria for the production of bioenergyLEONETTI JEAN-PAUL·Filed 2008·Granted Nov 10, 2015·6 cites·21 claims
- 1182US5962019AOral cyclosporin formulationsSANGSTAT MEDICAL CORP·Filed 1997·Granted Oct 5, 1999·65 cites·22 claims
- 1282US5223397ASoluble hla cross-matchSANGSTAT MEDICAL CORP·Filed 1991·Granted Jun 29, 1993·54 cites·14 claims
- 1381US5362654ASelf-contained quantitative assaySANGSTAT MEDICAL CORP·Filed 1993·Granted Nov 8, 1994·53 cites·11 claims
- 1479US6254885B1Oral cyclosphorin formulationsSANGSTAT MEDICAL CORP·Filed 1998·Granted Jul 3, 2001·47 cites·17 claims
- 1579US5834017AOral cyclopsporin formulationsSANGSTAT MEDICAL CORP·Filed 1995·Granted Nov 10, 1998·57 cites·20 claims
- 1679US5270169ADetection of HLA antigen-containing immune complexesSANGSTAT MEDICAL CORP·Filed 1992·Granted Dec 14, 1993·47 cites·17 claims
- 1778US5158869AAnalyte determination using comparison of juxtaposed competitive and non-competitive elisa results and device thereforeSANGSTAT MEDICAL CORP·Filed 1990·Granted Oct 27, 1992·61 cites·6 claims
- 1877US5292641AAlloantigen testing by binding assaySANGSTAT MEDICAL CORP·Filed 1991·Granted Mar 8, 1994·44 cites·4 claims
- 1976US5147780AMultiwell stat testSANGSTAT MEDICAL CORP·Filed 1991·Granted Sep 15, 1992·50 cites·4 claims
- 2073US2025275994A1Quinoline Derivatives For Use In The Treatment Of Inflammation DiseasesABIVAX·Filed 2024·Application pending·0 cites
- 2172US5256541ADetection of soluble alloantigen immune complexesSANGSTAT MEDICAL CORP·Filed 1991·Granted Oct 26, 1993·36 cites·5 claims
- 2272US2023323028A1Adhesive photoprotective compounds and uses thereofSKINOSIVE·Filed 2023·Application pending·0 cites
- 2371US2025032474A1Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulatorABIVAX·Filed 2024·Application pending·0 cites
- 2470US11826372B2Combinations including ABX196 for the treatment of cancerABIVAX·Filed 2021·Granted Nov 28, 2023·0 cites·9 claims
- 2569US11992499B2Quinoline derivatives for use in the treatment of inflammation diseasesABIVAX·Filed 2019·Granted May 28, 2024·0 cites·38 claims
- 2665US6541004B1Cocaethylene immunogens and antibodiesDRUGABUSE SCIENCES INC·Filed 2000·Granted Apr 1, 2003·3 cites·3 claims
- 2765US5939273AAnti α-gal screening techniqueSANGSTATE MEDICAL CORP·Filed 1997·Granted Aug 17, 1999·26 cites·6 claims
- 2865US2025352193A1Medical implant and delivery device for a medical implantHOLISTICK MEDICAL·Filed 2025·Application pending·0 cites
- 2964US2025170119A1Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulatorABIVAX·Filed 2023·Application pending·0 cites
- 3064US2025099454A1Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a jak inhibitorABIVAX·Filed 2023·Application pending·0 cites
- 3160US5256543AHLA typingSANGSTAT MEDICAL CORP·Filed 1991·Granted Oct 26, 1993·25 cites·17 claims
- 3258US11266667B2ABX196 for use in the treatment of bladder cancerABIVAX·Filed 2018·Granted Mar 8, 2022·0 cites·8 claims
- 3357US11278552B2Combinations including ABX196 for the treatment of cancerABIVAX·Filed 2017·Granted Mar 22, 2022·0 cites·10 claims
- 3457US2020397855A1Modulation of pla2-g1b in therapyDIACCURATE·Filed 2019·Application pending·0 cites
- 3556US5922548AAnti α-gal screening techniqueSANGSTAT MEDICAL CORP·Filed 1997·Granted Jul 13, 1999·15 cites·9 claims
- 3656US2022071985A1Quinoline derivatives for use in the treatment or prevention of cancerABIVAX·Filed 2019·Application pending·0 cites
- 3755US5714332AAnti α-gal screening techniqueSANGSTAT MEDICAL CORP·Filed 1996·Granted Feb 3, 1998·14 cites·3 claims
- 3855US2025114066A1Device and system for exchanging energy and/or data, in particular for localisation purposes, with at least one implant and/or at least one organ in a human or animal body and/or an apparatus external to the body via piezoelectric and/or capacitive transducersCARANX MEDICAL SAS·Filed 2022·Application pending·0 cites
- 3954US2023142547A1Compounds for treating or preventing a coronaviridae infection & methods and uses for assessing the occurrence of a coronaviridae infectionABIVAX·Filed 2021·Application pending·0 cites
- 4054US2020399392A1Inhibitors of pla2-g1b cofactors for treating cancerDIACCURATE·Filed 2019·Application pending·0 cites
- 4154US2002009441A1Reactively modified therapeutic compounds having an extended lifetime in vivoFiled 2001·Application pending·0 cites
- 4254US2023087008A1Adhesive photoprotective compounds and uses thereofSKINOSIVE·Filed 2020·Application pending·0 cites
- 4353US2022273530A1Bioadhesive particles comprising active agents, and uses thereofSKINOSIVE·Filed 2020·Application pending·0 cites
- 4453US2006002891A1Cytomodulating conjugates of members of specific binding pairsSANGSTAT MEDICAL CORP·Filed 2005·Application pending·0 cites
- 4553US2022145406A1Biomarkers, and uses in treatment of viral infections, inflammations, or cancerABIVAX·Filed 2019·Application pending·0 cites
- 4648US2016032329A1Use of bacteria for the production of bioenergyDEINOVE SA·Filed 2015·Application pending·0 cites
- 4747US5288648AMultiwell stat testSANGSTAT MEDICAL CORP·Filed 1992·Granted Feb 22, 1994·12 cites·10 claims
- 4847US2022287697A1Medical implant and delivery device for a medical implantHOLISTICK MEDICAL·Filed 2020·Application pending·0 cites
- 4945US2014142691A1Mitral Valve Replacement SystemNAKOSTECH SARL·Filed 2013·Application pending·0 cites
- 5045US2024156447A1Medical implant and catheter device for a medical implantHOLISTICK MEDICAL·Filed 2022·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Philippe Pouletty files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →